We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.
For more information, visit ipsen.com.
Pauta exclusiva para México:
Clave de Autorización COFEPRIS: 243300201B1962
CONSULTE A SU MÉDICO.
Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, and Primary Care
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.
For more information, visit ipsen.com.
Pauta exclusiva para México:
Clave de Autorización COFEPRIS: 243300201B1962
CONSULTE A SU MÉDICO.
Ipsen Global - A Biopharmaceutical Company | Innovation for Patient Care
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
R&D Logic it services, Software Development | Not capitalistic Partnership Event 29 Dec 2020 | | ||
Debiopharm biotech, deeptech, Pharmaceutical Manufacturing | Not capitalistic Partnership Event 24 Jun 2020 | | ||
BFM Bourse Online Audio and Video Media | Other 17 Dec 2021 | | ||
Collège des Directeurs du Développement Durable (C3D) greentech, cleantech, Civic and Social Organizations | Other 11 Jan 2022 | | ||
Top Employers Institute hrtech, Human Resources Services | Other 20 Jan 2022 | | ||
Foundation For Rare Diseases deeptech, Research Services | Other 31 May 2022 25 Jun 2024 | | | |
IDA Ireland International Trade and Development | Other 16 Feb 2022 | |